This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Annales de Dermatologie et de Vénéréologie | |
|---|---|
| Title | Annales de Dermatologie et de Vénéréologie |
| Discipline | Dermatology; Venereology |
| Language | French |
| Publisher | Société Française de Dermatologie |
| Country | France |
| Frequency | Monthly |
| History | 1870–present |
| Issn | 0151-9638 |
Annales de Dermatologie et de Vénéréologie is a peer-reviewed medical journal focused on clinical and experimental dermatology and venereology. Founded in the late 19th century, the journal has been associated with major French and European medical institutions and societies, serving as a vehicle for research communication among clinicians and researchers connected to Paris, Lyon, Marseille, Bordeaux, and other centers. It has published articles by authors affiliated with establishments such as Université Paris Cité, Université de Strasbourg, Assistance Publique – Hôpitaux de Paris, and international collaborators from Harvard Medical School, University of Oxford, Charité – Universitätsmedizin Berlin, University of Tokyo, and University of São Paulo.
Founded during a period of rapid professionalization in medicine, the journal emerged in the milieu of the Third French Republic alongside organizations like the Académie Nationale de Médecine and the Société de Biologie (Paris). Early contributors included physicians trained under figures associated with Louis Pasteur and contemporaries connected to Émile Roux, Jules Bordet, and practitioners influenced by the clinical traditions of Jean-Martin Charcot and Pierre Marie. During the interwar years, exchanges with German-speaking dermatologists from Vienna, Berlin, and Zurich expanded the journal’s profile, while post-World War II reconstruction linked it to initiatives led by World Health Organization collaborations and European bodies such as the European Society for Dermatological Research and the European Academy of Dermatology and Venereology.
The journal covers clinical case reports, randomized trials, epidemiological studies, histopathology reports, dermato-surgical techniques, and reviews on conditions such as psoriasis, atopic dermatitis, melanoma, basal cell carcinoma, squamous cell carcinoma, syphilis, HIV/AIDS, and sexually transmitted infections first described in 19th-century outbreaks like those studied by investigators in London, Edinburgh, and Vienna. It publishes content addressing diagnostic methods developed at centers such as Institut Pasteur, Institut Curie, Mayo Clinic, Johns Hopkins Hospital, and Mount Sinai Hospital. The journal also includes reports on therapeutic advances involving agents and organizations linked to GlaxoSmithKline, Novartis, Pfizer, Roche, and academic trials coordinated with National Institutes of Health units and national health agencies like Haute Autorité de Santé.
Published monthly, the journal’s editorial office has been staffed by editors affiliated with institutions such as Université Paris-Est Créteil Val de Seine, Université Grenoble Alpes, Centre Hospitalier Universitaire de Nantes, and international editorial board members from Stanford University School of Medicine, University College London, Karolinska Institutet, McGill University, and University of Melbourne. The publisher, historically linked to the Société Française de Dermatologie, coordinates peer review with reviewers drawn from societies including the International Society of Dermatology, the American Academy of Dermatology, and the Asian Academy of Dermatology and Venereology. The journal has transitioned through print runs managed by publishing houses with histories connected to firms operating in Paris and Geneva.
The journal is indexed in major biomedical databases alongside titles from publishers such as Elsevier, Springer Nature, Wiley-Blackwell, and Taylor & Francis. It appears in abstracting services used by libraries at institutions like Columbia University, Sorbonne University, University of California, San Francisco, ETH Zurich, and Trinity College Dublin, and is searchable through platforms affiliated with organizations including Scopus, Web of Science, and national bibliographic services managed by agencies in France and Germany.
Over its history, the journal has influenced clinical practice and research priorities in regions including France, Belgium, Switzerland, Canada, Brazil, Japan, and South Africa. It has been cited in guidelines and consensus statements developed by bodies such as the European Centre for Disease Prevention and Control, the World Health Organization, the French Ministry of Health, and specialist societies including the International Psoriasis Council. The journal’s impact factor and citation metrics have been tracked by organizations like Clarivate and Elsevier and discussed in bibliometric analyses from university groups at Université de Montréal and King's College London.
Noteworthy publications have included early case series on cutaneous manifestations of systemic disease by clinicians in Paris and Lyon, seminal reports on drug-induced skin reactions referenced by regulatory agencies such as the Agence nationale de sécurité du médicament et des produits de santé, descriptive histopathology studies from laboratories at Institut Pasteur and Institut Curie, and multicenter trials involving collaborators at Hopital Saint-Louis, Hôpital Européen Georges-Pompidou, Hôpital Necker–Enfants Malades, and international centers such as Cleveland Clinic and Massachusetts General Hospital. The journal has also featured consensus statements co-authored with committees from European Dermatology Forum and position papers cited by panels convened by World Health Organization working groups.
Category:Dermatology journals Category:Medical journals published in France